MEDINET Co., Ltd. engages in cell processing business. It offers solutions for regenerative medicine and cell therapy. It operates through the Cell Processing and Regenerative Medical Products segments. The Cell Processing segment includes manufacturing of specific cell-processed products for medical institutions; contracts for clinical and trial cell processing from companies, universities, research institutions; and contracts for operation of cell culture processing facilities. The Regenerative Medical Products segment deals with research and development for the acquisition of manufacturing and marketing approval for regenerative medicine products. The company was founded by Yoshiji Kimura and Kohji Egawa on October 17, 1995 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company